2025-06-14 13:09:05 Source: Pundi AIAuthor: Spotlight
Views: 932 times
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists